carmofur has been researched along with Cancer of Digestive System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maeta, M | 1 |
| Koga, S | 1 |
| Yamane, T | 1 |
| Shimizu, N | 1 |
| Oda, M | 1 |
| Masaki, T | 1 |
| Yoshida, Y | 1 |
| Watnabe, S | 1 |
| Tanida, O | 1 |
| Kishimoto, H | 1 |
| Seo, Y | 1 |
| Hara, Y | 1 |
| Furusawa, M | 1 |
| Nakane, H | 1 |
| Saeki, K | 1 |
| Tsujitani, S | 1 |
| Sonoda, T | 1 |
| Nohtsuka, T | 1 |
| Kameda, K | 1 |
| Tomoda, H | 1 |
2 other studies available for carmofur and Cancer of Digestive System
| Article | Year |
|---|---|
[Combination chemotherapy with neocarzinostatin(NCS), HCFU and picibanil(NHO therapy) for advanced carcinoma of the digestive system--a comparative study with NF, and NFO therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Digestive System Neoplasms; Drug Admini | 1984 |
[5-FU concentration in portal blood after oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU)].
Topics: Administration, Oral; Antineoplastic Agents; Digestive System Neoplasms; Drug Combinations; Fluorour | 1988 |